Ashraf Askar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ashraf Askar has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Adel ElSayed
Department of Internal Medicine, Faculty of Medicine, Sohag University
1 shared publication - Ahmed Sadek
Department of Hepatology and Gastroenterology, Theodor Bilharz Research Institute, Imbaba Giza, Egypt
1 shared publication - Ashraf Elyamany
Department of Medical oncology south Egypt cancer institute Assiut University, Assiut, Egypt
1 shared publication - El-Zahraa M. Meghezel
Tropical Medicine & Gastroentrology, Sohag University, Sohag, Egypt
1 shared publication - Emad Eldin Nabil
Clinical Oncology Department, Sohag University Hospital, Faculty of Medicine, Sohag University, Sohag, Egypt
1 shared publication - Eman Refaat Youness
Medical Biochemistry Department, Medical Research Institute, National Research Centre, Cairo, Egypt
1 shared publication
Latest Publications
- Open Access
- 20 March 2024
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 17 (1) , 435-442
Helicobacter Pylori Infection and Microalbuminuria in Diabetic Patients
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.
- 20 March 2024
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 17 (1) , 435-442
Open AccessHelicobacter Pylori Infection and Microalbuminuria in Diabetic Patients
Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.
- Open Access
- 4 October 2018
- Published by Open Access Pub in Journal of Hematology and Oncology Research
- Vol. 3 (2) , 23-34
Role of Tie2, CD14, Angiopoietin as Angiogenetic Markers in Hepatocellular Carcinoma Complicating Hepatitis C Virus Infection
Background Identifying biomarkers for early detection of hepatocellular carcinoma (HCC) remains quite challenging. In this study we aimed to estimate the number of TIE2-expressing monocytes (TEMs) cells, which display pro-tumoral activities and are defined as CD14+, TIE2+, and angiopoietin-2; and its potential use as a possible diagnostic marker in HCC patients complicating HCV induced cirrhosis. Methods Current study was conducted on 112 patients. They were divided into two groups: Group I (78 patients) with HCC complicating HCV induced cirrhosis; and group II chronic hepatitis C patients (34 patients). Both groups were compared to (age and sex-matched) healthy persons as group III (38 persons). Result The number of the circulating TEMs: CD14+ and TIE2+ monocytes were significantly higher in the peripheral blood of HCC patients than HCV LC patients and healthy controls, sensitivity and specificity for HCC diagnosis were respectively: CD14 (89.7%, 83.3%), TIE 2 (76.9%, 83.3%), and Ang-2 (76.9%, 66.7%). Moreover, analysis of the P-value and the odd’s ratio showed that CD14 has the highest predictive value for HCC. Conclusion Our results suggest that TEMs and Ang-2can be used as diagnostic markers for HCC, especially among the high-risk group of patients.
- 4 October 2018
- Published by Open Access Pub in Journal of Hematology and Oncology Research
- Vol. 3 (2) , 23-34
Open AccessRole of Tie2, CD14, Angiopoietin as Angiogenetic Markers in Hepatocellular Carcinoma Complicating Hepatitis C Virus Infection
Background Identifying biomarkers for early detection of hepatocellular carcinoma (HCC) remains quite challenging. In this study we aimed to estimate the number of TIE2-expressing monocytes (TEMs) cells, which display pro-tumoral activities and are defined as CD14+, TIE2+, and angiopoietin-2; and its potential use as a possible diagnostic marker in HCC patients complicating HCV induced cirrhosis. Methods Current study was conducted on 112 patients. They were divided into two groups: Group I (78 patients) with HCC complicating HCV induced cirrhosis; and group II chronic hepatitis C patients (34 patients). Both groups were compared to (age and sex-matched) healthy persons as group III (38 persons). Result The number of the circulating TEMs: CD14+ and TIE2+ monocytes were significantly higher in the peripheral blood of HCC patients than HCV LC patients and healthy controls, sensitivity and specificity for HCC diagnosis were respectively: CD14 (89.7%, 83.3%), TIE 2 (76.9%, 83.3%), and Ang-2 (76.9%, 66.7%). Moreover, analysis of the P-value and the odd’s ratio showed that CD14 has the highest predictive value for HCC. Conclusion Our results suggest that TEMs and Ang-2can be used as diagnostic markers for HCC, especially among the high-risk group of patients.